n-depropylpropafenone has been researched along with lumefantrine in 1 studies
| Studies (n-depropylpropafenone) | Trials (n-depropylpropafenone) | Recent Studies (post-2010) (n-depropylpropafenone) | Studies (lumefantrine) | Trials (lumefantrine) | Recent Studies (post-2010) (lumefantrine) |
|---|---|---|---|---|---|
| 20 | 2 | 2 | 487 | 123 | 298 |
| Protein | Taxonomy | n-depropylpropafenone (IC50) | lumefantrine (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.5351 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
1 other study(ies) available for n-depropylpropafenone and lumefantrine
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |